A direct comparison of pharmacodynamics and pharmacokinetics of insulin detemir and neutral protamine lispro (NPL) insulin in subjects with type 1 diabetes

被引：0
|
作者：
Korsatko, S. [1 ]
Glettler, K. [1 ]
Olsen, K. J. [2 ]
Wutte, A. [1 ]
Bock, G. [1 ]
Koehler, G. [1 ]
Mader, J. K. [1 ]
Semlitsch, B. [1 ]
Pieber, T. R. [1 ]
机构：
[1] Med Univ Graz, Dept Internal Med, Graz, Austria
[2] Larix ApS, Ballerup, Denmark
来源：
DIABETOLOGIA | 2009年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
499
引用
收藏
页码：S200 / S200
页数：1
相关论文
共 50 条
  • [1] Comparison of pharmacodynamic and pharmacokinetic properties of insulin detemir and neutral protamine lispro (NPL) insulin in patients with Type 1 Diabetes.
    Korsatko, Stefan
    Gettler, Katharina
    Olsen, Klaus Juel
    Wutte, Andrea
    Bock, Gerlies
    Koehler, Gerd
    Mader, Julia
    Semlitsch, Barbara
    Pieber, Thomas
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2009, 121 : S17 - S17
  • [2] A direct comparison of the pharmacodynamic properties of insulin detemir and neutral protamine lispro insulin in patients with type 1 diabetes
    Korsatko, S.
    Glettler, K.
    Olsen, K. J.
    Wutte, A.
    Bock, G.
    Koehler, G.
    Mader, J. K.
    Semlitsch, B.
    Pieber, T. R.
    [J]. DIABETES OBESITY & METABOLISM, 2013, 15 (03): : 241 - 245
  • [3] Pharmacokinetics and pharmacodynamics of insulin lispro protamine suspension compared with insulin glargine and insulin detemir in type 2 diabetes
    Hompesch, Marcus
    Ocheltree, Scott M.
    Wondmagegnehu, Eshetu T.
    Morrow, Linda A.
    Kollmeier, Alexa P.
    Campaigne, Barbara N.
    Jacober, Scott J.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (11) : 2679 - 2687
  • [4] Comparison of insulin lispro protamine suspension and insulin detemir in basal-bolus therapy in patients with Type 1 diabetes
    Chacra, A. R.
    Kipnes, M.
    Ilag, L. L.
    Sarwat, S.
    Giaconia, J.
    Chan, J.
    [J]. DIABETIC MEDICINE, 2010, 27 (05) : 563 - 569
  • [5] Comparison of pharmacodynamic intrasubject variability of insulin lispro protamine suspension and insulin glargine in subjects with type 1 diabetes
    Ocheltree, S. M.
    Hompesch, M.
    Wondmagegnehu, E. T.
    Morrow, L.
    Win, K.
    Jacober, S. J.
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2010, 163 (02) : 217 - 223
  • [6] Comparison of Pharmacokinetics and Pharmacodynamics of Inhaled Technosphere Insulin and Subcutaneous Insulin Lispro in the Treatment of Type 1 Diabetes Mellitus
    Marshall Grant
    Tim Heise
    Robert Baughman
    [J]. Clinical Pharmacokinetics, 2022, 61 : 413 - 422
  • [7] Comparison of Pharmacokinetics and Pharmacodynamics of Inhaled Technosphere Insulin and Subcutaneous Insulin Lispro in the Treatment of Type 1 Diabetes Mellitus
    Grant, Marshall
    Heise, Tim
    Baughman, Robert
    [J]. CLINICAL PHARMACOKINETICS, 2022, 61 (03) : 413 - 422
  • [8] Glucose-lowering effect and glycaemic variability of insulin glargine, insulin detemir and insulin lispro protamine in people with type 1 diabetes
    Derosa, G.
    Franzetti, I.
    Querci, F.
    Romano, D.
    D'Angelo, A.
    Maffioli, P.
    [J]. DIABETES OBESITY & METABOLISM, 2015, 17 (06): : 554 - 559
  • [9] Comparison of the pharmacodynamics and pharmacokinetics of bolus subcutaneous insulin glulisine and insulin lispro in obese patients with type 2 diabetes
    Luzio, SD
    Peter, R
    Dunseath, GJ
    Mustafa, N
    Owens, DR
    [J]. DIABETOLOGIA, 2005, 48 : A307 - A307
  • [10] A comparison of insulin detemir and neutral protamine Hagedorn (isophane) insulin in the treatment of diabetes: a systematic review
    Frier, B. M.
    Russell-Jones, D.
    Heise, T.
    [J]. DIABETES OBESITY & METABOLISM, 2013, 15 (11): : 978 - 986
12345